Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 50036060
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003524([4-(2,2-Diphenyl-propionyl)-piperazin-1-yl]-pyridi...)
Affinity DataIC50: 1.90nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003499(CHEMBL338940 | [4-(3-Hydroxy-3,3-diphenyl-propiony...)
Affinity DataIC50: 2.70nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003525(CHEMBL133742 | [4-(2,3-Diphenyl-acryloyl)-piperazi...)
Affinity DataIC50: 7.5nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003506(CHEMBL545771 | CHEMBL322184 | {4-[2-(Benzhydryl-am...)
Affinity DataIC50: 9.10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003473(CHEMBL317193 | [4-(3,3-Diphenyl-acryloyl)-piperazi...)
Affinity DataIC50: 10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003522(CHEMBL335113 | (4-Diphenylacetyl-piperazin-1-yl)-p...)
Affinity DataIC50: 10nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003514([4-(2-Benzyl-3-phenyl-propionyl)-piperazin-1-yl]-p...)
Affinity DataIC50: 11nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003503(CHEMBL335432 | 1-(3,3-Diphenyl-propionyl)-4-(pyrid...)
Affinity DataIC50: 15nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003490(CHEMBL101245 | [4-(3,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50: 20nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003519([4-(2-Phenyl-propionyl)-piperazin-1-yl]-pyridin-3-...)
Affinity DataIC50: 21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003494(CHEMBL336612 | [4-(3,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50: 21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003510([4-(3-Hydroxy-3,3-diphenyl-propionyl)-piperazin-1-...)
Affinity DataIC50: 21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003536(CHEMBL340544 | (1-Diphenylacetyl-piperidin-4-yl)-p...)
Affinity DataIC50: 21nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003548(CHEMBL335853 | [4-(2,2-Diphenyl-thioacetyl)-pipera...)
Affinity DataIC50: 23nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003497(CHEMBL134123 | {1-[2-(Benzhydryl-amino)-acetyl]-pi...)
Affinity DataIC50: 24nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003544(CHEMBL132852 | {4-[2-(Benzyl-phenyl-amino)-acetyl]...)
Affinity DataIC50: 24nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003485(CHEMBL134143 | [1-(3,3-Diphenyl-propionyl)-piperid...)
Affinity DataIC50: 26nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003527(4-(Cyano-pyridin-3-yl-methyl)-piperazine-1-carboxy...)
Affinity DataIC50: 26nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003523(CHEMBL544607 | [4-(2-Dibenzylamino-acetyl)-piperaz...)
Affinity DataIC50: 32nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003484(CHEMBL336816 | N-{2-[4-(Cyano-pyridin-3-yl-methyl)...)
Affinity DataIC50: 36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003552(CHEMBL555567 | {4-[2-(Benzhydryl-amino)-ethyl]-pip...)
Affinity DataIC50: 36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003543(CHEMBL554463 | {4-[2-(1-Phenyl-ethylamino)-acetyl]...)
Affinity DataIC50: 36nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003474(CHEMBL545773 | {4-[2-(1,2-Diphenyl-ethylamino)-ace...)
Affinity DataIC50: 50nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003558([4-(3,3-Diphenyl-propionyl)-piperazin-1-yl]-pyridi...)
Affinity DataIC50: 51nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003489(CHEMBL103801 | {4-[3-(Benzhydryl-amino)-propionyl]...)
Affinity DataIC50: 53nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003556(CHEMBL133457 | {4-[3-(Benzhydryl-amino)-propionyl]...)
Affinity DataIC50: 55nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003528(CHEMBL545072 | {4-[2-(Benzhydryl-methyl-amino)-ace...)
Affinity DataIC50: 60nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003513(CHEMBL423524 | [4-(2-Naphthalen-1-yl-acetyl)-piper...)
Affinity DataIC50: 76nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003520(CHEMBL552805 | {4-[2-(3,3-Diphenyl-propylamino)-ac...)
Affinity DataIC50: 86nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003501(3,3-Diphenyl-1-[4-(pyridin-3-ylamino)-piperidin-1-...)
Affinity DataIC50: 87nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50000714(3-[4-(2-Chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a...)
Affinity DataIC50: 91nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003537(CHEMBL134094 | [4-(2-Phenylamino-acetyl)-piperazin...)
Affinity DataIC50: 130nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003493(CHEMBL335176 | 1-[2-(Benzhydryl-amino)-acetyl]-4-(...)
Affinity DataIC50: 200nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003475(CHEMBL543420 | {4-[2-(2,2-Diphenyl-ethylamino)-ace...)
Affinity DataIC50: 220nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003516(CHEMBL335044 | [4-(2,3-Diphenyl-propionyl)-piperaz...)
Affinity DataIC50: 230nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003526(CHEMBL130034 | 2-[4-(Cyano-pyridin-3-yl-methyl)-pi...)
Affinity DataIC50: 240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003551(CHEMBL133921 | 2-(4-Diphenylacetyl-piperazin-1-yl)...)
Affinity DataIC50: 240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003511(CHEMBL545306 | (4-{2-[Methyl-(1-phenyl-ethyl)-amin...)
Affinity DataIC50: 240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003504([4-(2-Benzylamino-acetyl)-piperazin-1-yl]-pyridin-...)
Affinity DataIC50: 240nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003509(CHEMBL335556 | [4-(4-Phenyl-butyryl)-piperazin-1-y...)
Affinity DataIC50: 260nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003486(CHEMBL131597 | 4-(Cyano-pyridin-3-yl-methyl)-piper...)
Affinity DataIC50: 360nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003481(Pyridin-3-yl-{4-[3-(3,4,5-trimethoxy-phenyl)-propi...)
Affinity DataIC50: 400nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003557(CHEMBL559013 | [4-(2-1H-Indol-3-yl-acetyl)-piperaz...)
Affinity DataIC50: 450nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003496(CHEMBL133425 | Pyridin-3-yl-{4-[2-(3,4,5-trimethox...)
Affinity DataIC50: 460nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003517([4-(3-Phenyl-propionyl)-piperazin-1-yl]-pyridin-3-...)
Affinity DataIC50: 520nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003488(CHEMBL131690 | 3,3-Diphenyl-1-(4-pyridin-3-ylmethy...)
Affinity DataIC50: 520nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50368448(CHEMBL1203313)
Affinity DataIC50: 530nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003542(CHEMBL542731 | [4-(3,3-Diphenyl-propyl)-piperazin-...)
Affinity DataIC50: 630nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003530(CHEMBL340989 | N-{2-[4-(Cyano-pyridin-4-yl-methyl)...)
Affinity DataIC50: 680nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
TargetPlatelet-activating factor receptor(Guinea pig)
J. Uriach & C£A.S.A.

Curated by ChEMBL
LigandPNGBDBM50003505(CHEMBL132636 | [4-(2-Naphthalen-2-yl-acetyl)-piper...)
Affinity DataIC50: 720nMAssay Description:Concentration tested in vitro to inhibit PAF-induced maximum aggregation (PAF-Antagonistic activity) by 50%.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: